Abstract:Competitive bacteria-bacteriophage interactions have resulted in the evolution of a plethora of bacterial defense systems preventing phage propagation. In recent years, computational and bioinformatic approaches have underpinned the discovery of numerous novel bacterial defense systems. Anti-phage systems are frequently encoded together in genomic loci termed defense islands. Here we report the identification and characterisation of a novel anti-phage system, that we have termed Shield, which forms part of the Pseudomonas defensive arsenal. The Shield system comprises the core component ShdA, a membrane-bound protein harboring an RmuC domain. Heterologous production of ShdA alone is sufficient to mediate bacterial immunity against several phages. We demonstrate that Shield and ShdA confer population-level immunity and that they can also decrease transformation efficiency. We further show that ShdA homologues can degrade DNA in vitro and, when expressed in a heterologous host, can alter the organisation of the host chromosomal DNA. Use of comparative genomic approaches identified how Shield can be divided into four subtypes, three of which contain additional components that in some cases can negatively affect the activity of ShdA and/or provide additional lines of phage defense. Collectively, our results identify a new player within the Pseudomonas bacterial immunity arsenal that displays a novel mechanism of protection, and reveals a role for RmuC domains in phage defense. The evolutionary pressure exerted by bacteriophages has driven bacteria to acquire numerous defense systems. Recent studies have highlighted the extraordinary diversity of these systems, uncovering exciting links between bacterial and eukaryotic immunity. Here we describe a novel anti-phage system, named Shield, found within Pseudomonas species. We identify several Shield subtypes, all harboring the same core component, and describe its mode of action. The growing instance of multidrug-resistant bacterial infections urgently requires the development of alternative treatments. Phage therapy is a particularly pertinent approach to treat multi-drug resistant Pseudomonas aeruginosa strains causing severe lung infection in cystic fibrosis patients. A detailed understanding of bacterial immunity and phage counter-strategies is an essential step to underpin the rational design of phage therapy to fight disease.

Structure and Mechanism of Zorya Anti-Phage Defense System

The novel anti-phage system Shield co-opts an RmuC domain to mediate phage defense across Pseudomonas species

Bacterial defense systems exhibit synergistic anti-phage activity

Structural basis for the concerted antiphage activity in the SIR2–HerA system

Molecular and structural basis of an ATPase-nuclease dual-enzyme anti-phage defense complex

Multiple enzymatic activities of a Sir2-HerA system cooperate for anti-phage defense

Architecture and infection-sensing mechanism of the bacterial PARIS defense system

Architecture and activation mechanism of the bacterial PARIS defence system

Phage defence loci of Streptococcus thermophilus— tip of the anti-phage iceberg?

Ocr-mediated suppression of BrxX unveils a phage counter-defense mechanism

Genomic Characterization of Phage ZP3 and Its Endolysin LysZP with Antimicrobial Potential against Xanthomonas oryzae pv. oryzae

Structures and activation mechanism of the Gabija anti-phage system

Characterization of a lipid-based jumbo phage compartment as a hub for early phage infection

Structure-functional characterization of Lactococcus AbiA phage defense system

Structural characterization of macro domain–containing Thoeris antiphage defense systems

A Type IV restriction system targets glucosylated 5-hydroxyl methyl cytosine to protect against phage infection

Structure-guided discovery of anti-CRISPR and anti-phage defense proteins

Phage resistance profiling identifies new genes required for biogenesis and modification of the corynebacterial cell envelope

The mechanism of the phage-encoded protein antibiotic from ΦX174

Defining the constituents and functions of a lipid-based jumbo phage compartment

Systematic Discovery of Phage Genes that Inactivate Bacterial Immune Systems